These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37566006)

  • 1. Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the
    Premoli M; Fyke W; Bellocchio L; Lemaire V; Wolley-Roberts M; Bontempi B; Pietropaolo S
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperacusis in the Adult
    Ferraguto C; Bouleau Y; Peineau T; Dulon D; Pietropaolo S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
    Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T
    Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
    Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
    Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
    Bilousova TV; Dansie L; Ngo M; Aye J; Charles JR; Ethell DW; Ethell IM
    J Med Genet; 2009 Feb; 46(2):94-102. PubMed ID: 18835858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
    Dansie LE; Phommahaxay K; Okusanya AG; Uwadia J; Huang M; Rotschafer SE; Razak KA; Ethell DW; Ethell IM
    Neuroscience; 2013 Aug; 246():186-98. PubMed ID: 23660195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
    Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
    Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
    Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
    Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agmatine relieves behavioral impairments in Fragile X mice model.
    Jeon SJ; Kwon H; Bae HJ; Gonzales EL; Kim J; Chung HJ; Kim DH; Ryu JH; Shin CY
    Neuropharmacology; 2022 Nov; 219():109234. PubMed ID: 36057317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.
    Gaudissard J; Ginger M; Premoli M; Memo M; Frick A; Pietropaolo S
    Autism Res; 2017 Oct; 10(10):1584-1596. PubMed ID: 28590057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained correction of hippocampal neurogenic and cognitive deficits after a brief treatment by Nutlin-3 in a mouse model of fragile X syndrome.
    Javadi S; Li Y; Sheng J; Zhao L; Fu Y; Wang D; Zhao X
    BMC Med; 2022 May; 20(1):163. PubMed ID: 35549943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.
    Martinez LA; Tejada-Simon MV
    Mol Neurobiol; 2018 Jun; 55(6):4529-4542. PubMed ID: 28688003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant.
    Pop AS; Levenga J; de Esch CE; Buijsen RA; Nieuwenhuizen IM; Li T; Isaacs A; Gasparini F; Oostra BA; Willemsen R
    Psychopharmacology (Berl); 2014 Mar; 231(6):1227-35. PubMed ID: 23254376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome.
    Rosenheck M; Sheeler C; Saré RM; Gurney ME; Smith CB
    Neurobiol Dis; 2021 Nov; 159():105485. PubMed ID: 34411704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.